Alzheimers Disease: – Axonyx Reports Phenserine Associated with Significant Amyloid …
Axonyx Reports Phenserine Associated with Significant Amyloid …
Genetic Engineering News, NY - Feb 14, 2006… considers these results to support Phenserine’s dual mechanisms of action, which would differentiate it as a potential treatment for Alzheimer’s disease. …
Alzheimer’s Disease Neuroimaging Study Launched Nationwide by the …
Kansas City infoZine, MO - Feb 11, 2006Washington, DC – infoZine – The Alzheimer’s Disease Neuroimaging Initiative (ADNI) — a project developed by the National Institutes of Health (NIH) — is …
Compounds in blackcurrants could prevent Alzheimer’s disease
News-Medical.net, Australia - Jan 18, 2006Compounds in blackcurrants could prevent Alzheimer’s disease and the characteristics of British berries suggest they do it best, writes Jennifer Rohn in …
Memory Pharmaceuticals to Announce Fourth Quarter and Full Year …
PharmaLive.com (press release), PA - 16 hours ago… company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer’s disease, schizophrenia, depression …
Alzheimer’s risk ‘is 80% genetic’
BBC News, UK - Feb 11, 2006Up to 80% of the risk of developing Alzheimer’s disease is genetic, a study has suggested. US researchers looked at almost 400 sets …
Related posts:
- Alzheimers Disease: – Axonyx’ Alzheimer’s Candidate Appears Safe in Trial
- Alzheimers Disease: – Eisai Reports Results from Latest Donepezil Study in Vascular …
- Alzheimers Disease: – Optics Tests For Early Alzheimer’s Diagnosis Make Significant …
- Cortex Reports Third Quarter Results
- Cerebral Amyloid Angiopathy in Alzheimer’s Disease and Related